该产品是授权默克制药公司于2005年。

This product was licensed from Merck, KGaA in 2005.

youdao

去年下旬，默克制药公司透露其正面临与美国及加拿大税务部门的四起纠纷，这可能要使它耗资56亿美元来支付那些多余税收和利息的费用。

Late last year Merck, a drugs company, disclosed that it is facing four disputes with American and Canadian tax authorities that could cost it $5.6 billion in additional taxes and interest.

youdao

投资者表示，他们也正在起诉默克制药公司。由于默克制药公司有意淡化了万络的风险，在万络退出市场之后，投资者在股市中损失了数十亿美元。

Investors are also suing Merck, saying it played down the risks of Vioxx and cost them billions of dollars in stock value after the drug was removed from the market.

youdao